Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
ConclusionOur findings support the potential role of fecal calprotectin as a biomarker of intestinal inflammation in COVID-19 as a consequence of hypoxic intestinal damage and as suggested by the reduced P/F ratio.
Source: Gut Pathogens - Category: Microbiology Source Type: research
More News: Coronavirus | COVID-19 | Gastroenterology | Microbiology | Pneumonia | Respiratory Medicine | Study